| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 167 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 152 |
| 2 | TACROLIMUS OINTMENT 0.1% | 152 |
| 3 | MYCOPHENOLATE MOFETIL | 59 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 59 |
| 5 | PREDNISONE | 48 |
| 6 | METHOTREXATE | 33 |
| 7 | METHOTREXATE SODIUM | 33 |
| 8 | CYCLOSPORINE | 28 |
| 9 | PREDNISOLONE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| 1 | DARUNAVIR 600 MG | 9 | 0.0015 |
| 2 | TACROLIMUS OINTMENT 0.1% | 152 | 0.0012 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 152 | 0.0012 |
| 4 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 9 | 0.0011 |
| 5 | BASILIXIMAB | 13 | 0.0011 |
| 6 | TACROLIMUS | 167 | 0.0010 |
| 7 | FOSCARNET SODIUM | 4 | 0.0010 |
| 8 | ABACAVIR SULFATE | 9 | 0.0009 |
| 9 | BUSULFAN | 13 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0005 |
| 1 | Vasopressin V2 Receptor Antagonist [EPC] | 4 | 0.0003 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 28 | 0.0002 |
| 3 | Protease Inhibitor [EPC] | 9 | 0.0002 |
| 4 | Central alpha-2 Adrenergic Agonist [EPC] | 9 | 0.0002 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 9 | 0.0001 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 24 | 0.0001 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 33 | 0.0001 |